Late diagnosis of CHD and its associated factors in Kenya: an analytic cross-sectional study

Mercy Ng'eno1, Del-Rossi S Quadros1, Naomi Gachara1

  • 1Department of Paediatrics and Child Health, Aga Khan University Hospital, Nairobi, Kenya.

Cardiology in the Young
|November 4, 2022
PubMed

Insights

Late diagnosis of congenital heart disease (CHD) is high in Kenya, affecting 60.6% of pediatric patients. Parental education significantly impacts early detection, highlighting a need for improved screening initiatives.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Medical Diagnostics

Background:

  • Congenital heart disease (CHD) burden in Africa is underestimated due to under-reporting and high fetal/neonatal mortality.
  • Late diagnosis of CHD contributes to increased morbidity and mortality in pediatric populations.

Purpose of the Study:

  • To determine the prevalence of late diagnosis of CHD in Kenyan children.
  • To identify factors associated with the late diagnosis of congenital heart disease.

Main Methods:

  • A 5-year cross-sectional study (2011-2016) included 411 pediatric patients (0-18 years) with CHD.
  • Patients were categorized into early (<1 year) and late (>1 year) diagnosis groups.
  • Multiple logistic regression analyzed factors associated with late CHD diagnosis.

Main Results:

  • The prevalence of late CHD diagnosis was 60.6% (95% CI 55.7-65.3), with a median diagnosis age of 15 months.
  • Higher parental education levels (OR=4.99) were strongly associated with decreased odds of late diagnosis.
  • Cardiac murmur presence (OR=0.87) was associated with decreased odds of late diagnosis; other factors lacked statistical significance.

Conclusions:

  • Late diagnosis of congenital heart disease is a significant issue in Kenya.
  • Enhancing early detection and screening programs for CHD is crucial to reduce adverse outcomes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
43
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19